155 related articles for article (PubMed ID: 30198643)
1. Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
Sokol EA; Engelmann R; Kang W; Pinto N; Starkey A; Lai H; Nadel H; Shulkin BL; Pu Y; Appelbaum D; Yanik GA; Cohn SL; Armato SG; Volchenboum S
Pediatr Blood Cancer; 2018 Dec; 65(12):e27417. PubMed ID: 30198643
[TBL] [Abstract][Full Text] [Related]
2. Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.
Decarolis B; Schneider C; Hero B; Simon T; Volland R; Roels F; Dietlein M; Berthold F; Schmidt M
J Clin Oncol; 2013 Mar; 31(7):944-51. PubMed ID: 23341514
[TBL] [Abstract][Full Text] [Related]
3. The Association between Tumour Markers and Meta-iodobenzylguanidine Scans in South African Children with High-risk Neuroblastoma.
Van Heerden J; Kruger M; Esterhuizen TM; Hendricks M; Du Plessis J; Engelbrecht G; Janse van Vuuren M; van Emmenes B; Uys R; Burger C; Nyakale N; More S; Brink A
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):517-526. PubMed ID: 33781675
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
Messina JA; Cheng SC; Franc BL; Charron M; Shulkin B; To B; Maris JM; Yanik G; Hawkins RA; Matthay KK
Pediatr Blood Cancer; 2006 Dec; 47(7):865-74. PubMed ID: 16444675
[TBL] [Abstract][Full Text] [Related]
5. Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
Yanik GA; Parisi MT; Shulkin BL; Naranjo A; Kreissman SG; London WB; Villablanca JG; Maris JM; Park JR; Cohn SL; McGrady P; Matthay KK
J Nucl Med; 2013 Apr; 54(4):541-8. PubMed ID: 23440556
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
Naranjo A; Parisi MT; Shulkin BL; London WB; Matthay KK; Kreissman SG; Yanik GA
Pediatr Blood Cancer; 2011 Jul; 56(7):1041-5. PubMed ID: 21328522
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
[TBL] [Abstract][Full Text] [Related]
8. Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values.
Černý I; Prášek J; Kašpárková H
Nuklearmedizin; 2016 Aug; 55(4):151-7. PubMed ID: 27054367
[TBL] [Abstract][Full Text] [Related]
9. Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
Yanik GA; Parisi MT; Naranjo A; Nadel H; Gelfand MJ; Park JR; Ladenstein RL; Poetschger U; Boubaker A; Valteau-Couanet D; Lambert B; Castellani MR; Bar-Sever Z; Oudoux A; Kaminska A; Kreissman SG; Shulkin BL; Matthay KK
J Nucl Med; 2018 Mar; 59(3):502-508. PubMed ID: 28887399
[TBL] [Abstract][Full Text] [Related]
10. I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
Yang J; Codreanu I; Servaes S; Zhuang H
Nucl Med Commun; 2012 Nov; 33(11):1134-7. PubMed ID: 22825037
[TBL] [Abstract][Full Text] [Related]
11. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
Matthay KK; Edeline V; Lumbroso J; Tanguy ML; Asselain B; Zucker JM; Valteau-Couanet D; Hartmann O; Michon J
J Clin Oncol; 2003 Jul; 21(13):2486-91. PubMed ID: 12829667
[TBL] [Abstract][Full Text] [Related]
12. Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.
Frappaz D; Bonneu A; Chauvot P; Edeline V; Giammarile F; Siles S; Wioland M; Gomez F
Med Pediatr Oncol; 2000 Apr; 34(4):237-41. PubMed ID: 10742058
[TBL] [Abstract][Full Text] [Related]
13. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
[TBL] [Abstract][Full Text] [Related]
14. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
[TBL] [Abstract][Full Text] [Related]
15. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
16. Persistent positive metaiodobenzylguanidine scans after autologous peripheral blood stem cell transplantation may indicate maturation of stage 4 neuroblastoma.
Okamoto Y; Kodama Y; Nishikawa T; Rindiarti A; Tanabe T; Nakagawa S; Yoshioka T; Takumi K; Kaji T; Kawano Y
Pediatr Hematol Oncol; 2017 Apr; 34(3):157-164. PubMed ID: 28976242
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative localization of neuroblastoma in children with 123I- or 125I-radiolabeled metaiodobenzylguanidine.
Martelli H; Ricard M; Larroquet M; Wioland M; Paraf F; Fabre M; Josset P; Helardot PG; Gauthier F; Terrier-Lacombe MJ; Michon J; Hartmann O; Tabone MD; Patte C; Lumbroso J; Gruner M
Surgery; 1998 Jan; 123(1):51-7. PubMed ID: 9457223
[TBL] [Abstract][Full Text] [Related]
18.
Aboian MS; Huang SY; Hernandez-Pampaloni M; Hawkins RA; VanBrocklin HF; Huh Y; Vo KT; Gustafson WC; Matthay KK; Seo Y
J Nucl Med; 2021 Jan; 62(1):43-47. PubMed ID: 32414950
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the detecting capability between
Qiu ZL; Saito S; Kayano D; Wakabayashi H; Kinuya S
Ann Nucl Med; 2021 Jun; 35(6):649-661. PubMed ID: 33866530
[TBL] [Abstract][Full Text] [Related]
20. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
Kushner BH; Yeh SD; Kramer K; Larson SM; Cheung NK
J Clin Oncol; 2003 Mar; 21(6):1082-6. PubMed ID: 12637474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]